Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Laron syndrome"
Show Display Options
Rank Status Study
1 Completed IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
Conditions: Growth Hormone Insensitivity Syndrome (GHIS);   Laron Syndrome
Intervention: Drug: rhIGF-I/rhIGFBP-3
2 Active, not recruiting Long-Term Treatment With rhIGF-1 in GHIS
Condition: Growth Hormone Insensitivity Syndrome
Intervention: Drug: mecasermin

Indicates status has not been verified in more than two years